ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

New Carfilzomib Combination Produces Near Remissions

June 29, 2012

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

October 6, 2006

In Brief: Joseph Bertino Succeeds Bresnick As AACR President; Louise Strong Is President-Elect

March 31, 1995

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001